Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Various Advanced Cancer”

40 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 40 results

Testing effectiveness (Phase 2)Looking for participantsNCT05525247
What this trial is testing

A Phase 1/2, Open-label, Multicenter, Dose Escalation and Expansion Study of SLC-3010 Monotherapy and in Combination

Who this might be right for
Advanced Solid Tumor
Selecxine 420
Not applicableWithdrawnNCT04889495
What this trial is testing

A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer

Who this might be right for
Non-small Cell Lung CancerMetastatic Colorectal CancerMetastatic Breast Cancer+5 more
Pfizer
Early research (Phase 1)Study completedNCT01673737
What this trial is testing

A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced Cancer

Who this might be right for
Neoplasm Malignant
Sanofi 75
Not applicableUnknownNCT04831632
What this trial is testing

Diagnostic Performance Assessment of Qualitative Ifobt and Quantitative Ifobt for Advanced Neoplastic

Who this might be right for
Colorectal Neoplasms
CECILIA CURVALE 630
Early research (Phase 1)Study completedNCT00046423
What this trial is testing

A Trial of ABI-007 in Patients With Advanced Non-Hematologic Malignancies

Who this might be right for
NeoplasmsMetastases, Neoplasm
Celgene Corporation 20
Testing effectiveness (Phase 2)WithdrawnNCT03704077
What this trial is testing

An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric CancerCancer of the StomachStomach Cancer+1 more
Bristol-Myers Squibb
Early research (Phase 1)Study completedNCT05372367
What this trial is testing

A Study in People With Advanced Cancer to Test Whether the Amount of BI 907828 in the Blood is Influenced by Taking an OATP Inhibitor or a CYP3 Inhibitor

Who this might be right for
Solid Tumors
Boehringer Ingelheim 33
Early research (Phase 1)Study completedNCT00621725
What this trial is testing

Phase 1 PK Study of Cediranib in Single and Multiple Doses in Hepatically Impaired Patients With Solid Tumours

Who this might be right for
Advanced CancerHepatic Impairment
AstraZeneca 36
Testing effectiveness (Phase 2)Ended earlyNCT04913220
What this trial is testing

SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Cancers (Pegathor Skin 201)

Who this might be right for
Malignant MelanomaSquamous Cell Carcinoma of Skin
Sanofi 46
Not applicableLooking for participantsNCT07312760
What this trial is testing

Existential Distress in Advanced Cancer: Comparing a Short-term Psychodynamic Psychotherapy (ORPHYS) to Treatment as Usual (TAU)

Who this might be right for
Advanced Cancer, Various, NOS
Universitätsklinikum Hamburg-Eppendorf 160
Early research (Phase 1)Study completedNCT00701324
What this trial is testing

BI 811283 in Various Solid Tumours

Who this might be right for
Neoplasms
Boehringer Ingelheim 124
Not applicableLooking for participantsNCT05443087
What this trial is testing

TARGETed Therapy Drug MONITOring in DIGestive Oncology

Who this might be right for
Digestive CancerMetastatic Colorectal CancerHepatocellular Carcinoma+2 more
UNICANCER 330
Early research (Phase 1)Study completedNCT03335540
What this trial is testing

An Adaptive Study to Match Patients With Solid Tumors to Various Immunotherapy Combinations Based Upon a Broad Biomarker Assessment

Who this might be right for
Advanced Cancer
Bristol-Myers Squibb 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03473743
What this trial is testing

Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer

Who this might be right for
Urothelial Carcinoma
Janssen Research & Development, LLC 125
Early research (Phase 1)Study completedNCT01096355
What this trial is testing

Gamma-Secretase Inhibitor RO4929097 in Treating Patients With Metastatic or Unresectable Solid Malignancies

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 28
Early research (Phase 1)Study completedNCT01335269
What this trial is testing

BI 853520 in Patients With Various Types of Advanced or Metastatic Cancer

Who this might be right for
Neoplasms
Boehringer Ingelheim 96
Testing effectiveness (Phase 2)Looking for participantsNCT06943521
What this trial is testing

MT-4561 in Patients With Various Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)Non-small Cell Lung Cancer (NSCLC)Esophageal Cancer+13 more
Tanabe Pharma America, Inc. 27
Large-scale testing (Phase 3)Study completedNCT03143153
What this trial is testing

Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin

Who this might be right for
Various Advanced Cancer
Bristol-Myers Squibb 970
Early research (Phase 1)Study completedNCT00884546
What this trial is testing

Multiple Ascending Dose (MAD) Combination in Subjects With Multiple Myeloma

Who this might be right for
Advanced Cancer, Various, NOS
Bristol-Myers Squibb 27
Testing effectiveness (Phase 2)Study completedNCT02387996
What this trial is testing

Nivolumab in Participants With Metastatic or Unresectable Bladder Cancer

Who this might be right for
Various Advanced Cancer
Bristol-Myers Squibb 270
Load More Results